Galectin Therapeutics (GALT) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Galectin Therapeutics (GALT) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Galectin Therapeutics |
185.83 Mn |
171.73 Mn |
- |
54.71% |
| Date | Value |
|---|
| Mar 31, 2026 |
54.71% |
| Dec 31, 2025 |
75.91% |
| Sep 30, 2025 |
61.99% |
| Jun 30, 2025 |
71.53% |
| Mar 31, 2025 |
50.63% |
| Dec 31, 2024 |
36.17% |
| Sep 30, 2024 |
44.72% |
| Jun 30, 2024 |
35.76% |
| Mar 31, 2024 |
59.21% |
| Dec 31, 2023 |
67.30% |
| Sep 30, 2023 |
63.64% |
| Jun 30, 2023 |
67.17% |
| Mar 31, 2023 |
48.63% |
| Dec 31, 2022 |
-26.47% |
| Sep 30, 2022 |
97.44% |
| Jun 30, 2022 |
56.23% |
| Mar 31, 2022 |
84.76% |
| Dec 31, 2021 |
92.33% |
| Sep 30, 2021 |
-337.22% |
| Jun 30, 2021 |
66.83% |
